T1	AdverseReaction 53 73;80 88	Intraocular pressure increase
T2	AdverseReaction 137 145	glaucoma
T3	DrugClass 107 122	corticosteroids
T4	AdverseReaction 151 176	damage to the optic nerve
T5	AdverseReaction 178 202	defects in visual acuity
T6	AdverseReaction 178 185;207 223	defects fields of vision
T7	DrugClass 341 356	corticosteroids
T8	AdverseReaction 371 401	posterior subcapsular cataract
T9	DrugClass 461 469	steroids
T10	AdverseReaction 497 510	delay healing
T11	AdverseReaction 515 523;541 555	increase bleb formation
T12	AdverseReaction 617 629	perforations
T13	DrugClass 679 687	steroids
T14	DrugClass 1000 1015	corticosteroids
T15	AdverseReaction 1079 1106	secondary ocular infections
T16	DrugClass 1465 1473	steroids
T17	AdverseReaction 1505 1515;1537 1564	exacerbate viral infections of the eye
T18	AdverseReaction 1632 1663	Fungal infections of the cornea
T19	DrugClass 1734 1741	steroid
T20	DrugClass 2080 2095	corticosteroids
T21	AdverseReaction 2110 2118	glaucoma
T22	AdverseReaction 2124 2149	damage to the optic nerve
T23	AdverseReaction 2151 2175	defects in visual acuity
T24	AdverseReaction 2151 2158;2180 2196	defects fields of vision
T25	AdverseReaction 2416 2446	posterior subcapsular cataract
T26	DrugClass 2386 2401	corticosteroids
T27	DrugClass 2501 2509	steroids
T28	AdverseReaction 2537 2550	delay healing
T29	AdverseReaction 2555 2563;2581 2595	increase bleb formation
T30	AdverseReaction 2657 2669	perforations
T31	DrugClass 2719 2727	steroids
T32	DrugClass 3035 3050	corticosteroids
T33	AdverseReaction 3114 3141	secondary ocular infections
T34	DrugClass 3495 3503	steroids
T35	AdverseReaction 3535 3545;3567 3594	exacerbate viral infections of the eye
T36	AdverseReaction 3657 3688	Fungal infections of the cornea
T37	DrugClass 3759 3766	steroid
T38	AdverseReaction 75 78;80 88	IOP increase
T39	AdverseReaction 1020 1046	suppress the host response
T40	AdverseReaction 1505 1515;1576 1590	exacerbate herpes simplex
T41	AdverseReaction 3055 3081	suppress the host response
T42	AdverseReaction 3535 3545;3606 3620	exacerbate herpes simplex
E1	AdverseReaction:T1
E2	AdverseReaction:T2 Hypothetical:E3
E3	DrugClass:T3
E4	AdverseReaction:T4 Hypothetical:E3
E5	AdverseReaction:T5 Hypothetical:E3
E6	AdverseReaction:T6 Hypothetical:E3
E7	DrugClass:T7
E8	AdverseReaction:T8 Hypothetical:E7
E9	DrugClass:T9
E10	AdverseReaction:T10 Hypothetical:E9
E11	AdverseReaction:T11 Hypothetical:E9
E12	AdverseReaction:T12 Hypothetical:E13
E13	DrugClass:T13
E14	DrugClass:T14
E15	AdverseReaction:T15 Hypothetical:E14
E16	DrugClass:T16
E17	AdverseReaction:T17 Hypothetical:E16
E18	AdverseReaction:T18 Hypothetical:E19
E19	DrugClass:T19
E20	DrugClass:T20
E21	AdverseReaction:T21 Hypothetical:E20
E22	AdverseReaction:T22 Hypothetical:E20
E23	AdverseReaction:T23 Hypothetical:E20
E24	AdverseReaction:T24 Hypothetical:E20
E25	AdverseReaction:T25 Hypothetical:E26
E26	DrugClass:T26
E27	DrugClass:T27
E28	AdverseReaction:T28 Hypothetical:E27
E29	AdverseReaction:T29 Hypothetical:E27
E30	AdverseReaction:T30 Hypothetical:E31
E31	DrugClass:T31
E32	DrugClass:T32
E33	AdverseReaction:T33 Hypothetical:E32
E34	DrugClass:T34
E35	AdverseReaction:T35 Hypothetical:E34
E36	AdverseReaction:T36 Hypothetical:E37
E37	DrugClass:T37
E38	AdverseReaction:T38
E39	AdverseReaction:T39 Hypothetical:E14
E40	AdverseReaction:T40 Hypothetical:E16
E41	AdverseReaction:T41 Hypothetical:E32
E42	AdverseReaction:T42 Hypothetical:E34
A1	CUI E1 C0234708
A2	UMLS-Preferred-Name E1 Raised intraocular pressure
A3	MEDDRA-PT E1 Intraocular pressure increased
A4	MEDDRA-PT-ID E1 10022806
A5	CUI E2 C0017601
A6	UMLS-Preferred-Name E2 Glaucoma
A7	MEDDRA-PT E2 Glaucoma
A8	MEDDRA-PT-ID E2 10018304
A9	CUI E4 C0161398
A10	UMLS-Preferred-Name E4 Optic Nerve Injuries
A11	MEDDRA-PT E4 Optic nerve injury
A12	MEDDRA-PT-ID E4 10030938
A13	LLT E4 Optic nerve damage
A14	LLT-ID E4 10075452
A15	CUI E5 C0234632
A16	UMLS-Preferred-Name E5 Reduced visual acuity
A17	MEDDRA-PT E5 Visual acuity reduced
A18	MEDDRA-PT-ID E5 10047531
A19	CUI E6 C3887875
A20	UMLS-Preferred-Name E6 Visual field defects
A21	MEDDRA-PT E6 Visual field defect
A22	MEDDRA-PT-ID E6 10047555
A23	CUI E8 C0858617
A24	UMLS-Preferred-Name E8 Posterior subcapsular cataract
A25	MEDDRA-PT E8 Cataract subcapsular
A26	MEDDRA-PT-ID E8 10007764
A27	LLT E8 Posterior subcapsular cataract
A28	LLT-ID E8 10036364
A29	CUI E10 C0151692
A30	UMLS-Preferred-Name E10 Impaired wound healing
A31	MEDDRA-PT E10 Impaired healing
A32	MEDDRA-PT-ID E10 10021519
A33	LLT E10 Healing delayed
A34	LLT-ID E10 10019238
A35	flag E11 underspecified
A36	CUI E11 C0005758
A37	UMLS-Preferred-Name E11 Bulla
A38	MEDDRA-PT E11 Blister
A39	MEDDRA-PT-ID E11 10005191
A40	CUI E12 C0549099
A41	UMLS-Preferred-Name E12 Perforation (observation)
A42	MEDDRA-PT E12 Perforation
A43	MEDDRA-PT-ID E12 10076705
A44	CUI E15 C0015403
A45	UMLS-Preferred-Name E15 Eye Infections
A46	MEDDRA-PT E15 Eye infection
A47	MEDDRA-PT-ID E15 10015929
A48	CUI E17 C0015407
A49	UMLS-Preferred-Name E17 Eye Infections, Viral
A50	MEDDRA-PT E17 Eye infection viral
A51	MEDDRA-PT-ID E17 10015940
A52	flag E18 duplicate
A53	CUI E18 C0729777
A54	UMLS-Preferred-Name E18 Corneal infection
A55	MEDDRA-PT E18 Corneal infection
A56	MEDDRA-PT-ID E18 10061788
A57	CUI E21 C0017601
A58	UMLS-Preferred-Name E21 Glaucoma
A59	MEDDRA-PT E21 Glaucoma
A60	MEDDRA-PT-ID E21 10018304
A61	CUI E22 C0161398
A62	UMLS-Preferred-Name E22 Optic Nerve Injuries
A63	MEDDRA-PT E22 Optic nerve injury
A64	MEDDRA-PT-ID E22 10030938
A65	LLT E22 Optic nerve damage
A66	LLT-ID E22 10075452
A67	CUI E23 C0234632
A68	UMLS-Preferred-Name E23 Reduced visual acuity
A69	MEDDRA-PT E23 Visual acuity reduced
A70	MEDDRA-PT-ID E23 10047531
A71	CUI E24 C3887875
A72	UMLS-Preferred-Name E24 Visual field defects
A73	MEDDRA-PT E24 Visual field defect
A74	MEDDRA-PT-ID E24 10047555
A75	CUI E25 C0858617
A76	UMLS-Preferred-Name E25 Posterior subcapsular cataract
A77	MEDDRA-PT E25 Cataract subcapsular
A78	MEDDRA-PT-ID E25 10007764
A79	LLT E25 Posterior subcapsular cataract
A80	LLT-ID E25 10036364
A81	CUI E28 C0151692
A82	UMLS-Preferred-Name E28 Impaired wound healing
A83	MEDDRA-PT E28 Impaired healing
A84	MEDDRA-PT-ID E28 10021519
A85	LLT E28 Healing delayed
A86	LLT-ID E28 10019238
A87	flag E29 underspecified
A88	CUI E29 C0005758
A89	UMLS-Preferred-Name E29 Bulla
A90	MEDDRA-PT E29 Blister
A91	MEDDRA-PT-ID E29 10005191
A92	CUI E30 C0549099
A93	UMLS-Preferred-Name E30 Perforation (observation)
A94	MEDDRA-PT E30 Perforation
A95	MEDDRA-PT-ID E30 10076705
A96	CUI E33 C0015403
A97	UMLS-Preferred-Name E33 Eye Infections
A98	MEDDRA-PT E33 Eye infection
A99	MEDDRA-PT-ID E33 10015929
A100	CUI E35 C0015407
A101	UMLS-Preferred-Name E35 Eye Infections, Viral
A102	MEDDRA-PT E35 Eye infection viral
A103	MEDDRA-PT-ID E35 10015940
A104	flag E36 duplicate
A105	CUI E36 C0729777
A106	UMLS-Preferred-Name E36 Corneal infection
A107	MEDDRA-PT E36 Corneal infection
A108	MEDDRA-PT-ID E36 10061788
A109	CUI E38 C0234708
A110	UMLS-Preferred-Name E38 Raised intraocular pressure
A111	MEDDRA-PT E38 Intraocular pressure increased
A112	MEDDRA-PT-ID E38 10022806
A113	LLT E38 Increased intraocular pressure
A114	LLT-ID E38 10021667
A115	CUI E39 C1373218
A116	UMLS-Preferred-Name E39 Decreased Immunologic Activity [PE]
A117	MEDDRA-PT E39 Immunosuppression
A118	MEDDRA-PT-ID E39 10062016
A119	CUI E40 C0856138
A120	UMLS-Preferred-Name E40 Herpes simplex aggravated
A121	MEDDRA-PT E40 Herpes simplex
A122	MEDDRA-PT-ID E40 10019948
A123	LLT E40 Herpes simplex aggravated
A124	LLT-ID E40 10048418
A125	CUI E41 C1373218
A126	UMLS-Preferred-Name E41 Decreased Immunologic Activity [PE]
A127	MEDDRA-PT E41 Immunosuppression
A128	MEDDRA-PT-ID E41 10062016
A129	CUI E42 C0856138
A130	UMLS-Preferred-Name E42 Herpes simplex aggravated
A131	MEDDRA-PT E42 Herpes simplex
A132	MEDDRA-PT-ID E42 10019948
A133	LLT E42 Herpes simplex aggravated
A134	LLT-ID E42 10048418
